The Sterile Filtration market is expected to register a CAGR of 8% over the forecast period, owing to the growing pharmaceutical and biopharmaceutical companies and increasing investments into research and development activities. According to the European Federation of Pharmaceutical Industries and Associations, the overall sales of pharmaceutical industry worldwide was recorded to be approximately 852,647 million USD. Furthermore, emission of high concentration of high antibiotics on the manufacturing sites that might develop the new forms of pathogens. Hence, filtration is an immense part involved in manufacturing of drugs. The drugs need to be protected against introduction of unwanted bacterias, virus and other micro-organisms and ensure patient safety.

Key Market Trends

Membrane Segment is Expected to Exhibit a Significant Market Growth in the Sterile Filtration Market

Membrane is a type of filter that have a uniform sized pores that traps the micro-organisms. The adoption of biologics, cell-culture based vaccines, etc. is growing, which is expected to grow the demand for filtration. For developing these biologics, cell filtration is a crucial part as the culture needs to be protected against introduction of unwanted bacteria, virus and other micro-organisms. Hence, a proper membrane filter is of utmost importance.

Furthermore, the clarification process involves centrifugation, microfiltration and harvesting of the culture. Cell separation and removal of cell debris are the primary goals of this procedure, for which membranes are required. Thus, it is expected to impact positively on the sterile filtration market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Sterile Filtration market, owing to the increasing number of API manufacturing facilities and increasing investment by companies into R&D activities. As per the data of US FDA (Food & Drug Administration), in 2019, approximately 510 API facilities were present in the United States. Furthermore, according to the Pharmaceutical Research & Manufacturers of America, in 2018, around 79.6 billion USD was invested by biopharmaceutical companies in R&D activities. Hence, the aforementioned factors are expected to boost the demand for sterile filtration.

Competitive Landscape

The well-known companies in Sterile Filtration market are Danaher Corporation, Merck KGaA, ThermoFisher Scientific Inc., Sartorius AG, GE Healthcare, 3M, Cole-Parmer Instrument Company, LLC, Sterlitech Corporation, Eaton Corporation and Porvair Filtration Group.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support